Eiger BioPharmaceuticals, Inc.

Delisted

CIK 1305253fmd_1XY2AQ33GVNSMZ7DNZZ6BJMBBTManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2012 to Dec 31, 2023, 45 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).